Global Rheumatoid Arthritis Drugs Market Size, Status and Forecast 2027

Table of Contents

Global Rheumatoid Arthritis Drugs Market Size, Status and Forecast 2022
1 Industry Overview of Rheumatoid Arthritis Drugs
1.1 Rheumatoid Arthritis Drugs Market Overview
1.1.1 Rheumatoid Arthritis Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Global Rheumatoid Arthritis Drugs Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Rheumatoid Arthritis Drugs Market by Type
1.3.1 NSAIDs
1.3.2 DMARDs
1.3.3 Corticosteroids
1.3.4 Analgesics
1.3.5 Other
1.4 Rheumatoid Arthritis Drugs Market by End Users/Application
1.4.1 Hospitals
1.4.2 Clinics
1.4.3 Home Care
1.4.4 Other

2 Global Rheumatoid Arthritis Drugs Competition Analysis by Players
2.1 Rheumatoid Arthritis Drugs Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Merck
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Rheumatoid Arthritis Drugs Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Novartis
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Rheumatoid Arthritis Drugs Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Pfizer
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Rheumatoid Arthritis Drugs Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 J&J
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Rheumatoid Arthritis Drugs Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 BMS
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Rheumatoid Arthritis Drugs Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Abbvie
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Rheumatoid Arthritis Drugs Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Boehringer Ingelheim
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Rheumatoid Arthritis Drugs Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 AstraZeneca
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Rheumatoid Arthritis Drugs Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 MedImmune
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Rheumatoid Arthritis Drugs Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Takeda
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Rheumatoid Arthritis Drugs Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Biogen Idec
3.12 Celgene
3.13 Bristol-Myers Squibb
3.14 Celltrion

4 Global Rheumatoid Arthritis Drugs Market Size by Type and Application (2012-2017)
4.1 Global Rheumatoid Arthritis Drugs Market Size by Type (2012-2017)
4.2 Global Rheumatoid Arthritis Drugs Market Size by Application (2012-2017)
4.3 Potential Application of Rheumatoid Arthritis Drugs in Future
4.4 Top Consumer/End Users of Rheumatoid Arthritis Drugs

5 United States Rheumatoid Arthritis Drugs Development Status and Outlook
5.1 United States Rheumatoid Arthritis Drugs Market Size (2012-2017)
5.2 United States Rheumatoid Arthritis Drugs Market Size and Market Share by Players (2016 and 2017)

6 EU Rheumatoid Arthritis Drugs Development Status and Outlook
6.1 EU Rheumatoid Arthritis Drugs Market Size (2012-2017)
6.2 EU Rheumatoid Arthritis Drugs Market Size and Market Share by Players (2016 and 2017)

7 Japan Rheumatoid Arthritis Drugs Development Status and Outlook
7.1 Japan Rheumatoid Arthritis Drugs Market Size (2012-2017)
7.2 Japan Rheumatoid Arthritis Drugs Market Size and Market Share by Players (2016 and 2017)

8 China Rheumatoid Arthritis Drugs Development Status and Outlook
8.1 China Rheumatoid Arthritis Drugs Market Size (2012-2017)
8.2 China Rheumatoid Arthritis Drugs Market Size and Market Share by Players (2016 and 2017)

9 India Rheumatoid Arthritis Drugs Development Status and Outlook
9.1 India Rheumatoid Arthritis Drugs Market Size (2012-2017)
9.2 India Rheumatoid Arthritis Drugs Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Rheumatoid Arthritis Drugs Development Status and Outlook
10.1 Southeast Asia Rheumatoid Arthritis Drugs Market Size (2012-2017)
10.2 Southeast Asia Rheumatoid Arthritis Drugs Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Rheumatoid Arthritis Drugs Market Size (Value) by Regions (2017-2022)
11.1.1 United States Rheumatoid Arthritis Drugs Revenue and Growth Rate (2017-2022)
11.1.2 EU Rheumatoid Arthritis Drugs Revenue and Growth Rate (2017-2022)
11.1.3 Japan Rheumatoid Arthritis Drugs Revenue and Growth Rate (2017-2022)
11.1.4 China Rheumatoid Arthritis Drugs Revenue and Growth Rate (2017-2022)
11.1.5 India Rheumatoid Arthritis Drugs Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Rheumatoid Arthritis Drugs Revenue and Growth Rate (2017-2022)
11.2 Global Rheumatoid Arthritis Drugs Market Size (Value) by Type (2017-2022)
11.3 Global Rheumatoid Arthritis Drugs Market Size by Application (2017-2022)

12 Rheumatoid Arthritis Drugs Market Dynamics
12.1 Rheumatoid Arthritis Drugs Market Opportunities
12.2 Rheumatoid Arthritis Drugs Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Rheumatoid Arthritis Drugs Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Rheumatoid Arthritis Drugs Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source



List of Tables and Figures

Figure Rheumatoid Arthritis Drugs Product Scope
Figure Global Rheumatoid Arthritis Drugs Market Size (Million USD) (2012-2017)
Table Global Rheumatoid Arthritis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Rheumatoid Arthritis Drugs Market Share by Regions in 2016
Figure United States Rheumatoid Arthritis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Rheumatoid Arthritis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Rheumatoid Arthritis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Rheumatoid Arthritis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Rheumatoid Arthritis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Rheumatoid Arthritis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Rheumatoid Arthritis Drugs Market Share by Type in 2016
Figure NSAIDs Market Size (Million USD) and Growth Rate (2012-2017)
Figure DMARDs Market Size (Million USD) and Growth Rate (2012-2017)
Figure Corticosteroids Market Size (Million USD) and Growth Rate (2012-2017)
Figure Analgesics Market Size (Million USD) and Growth Rate (2012-2017)
Figure Other Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Rheumatoid Arthritis Drugs Market Share by Application in 2016
Table Key Downstream Customer in Hospitals
Figure Rheumatoid Arthritis Drugs Market Size (Million USD) and Growth Rate in Hospitals (2012-2017)
Table Key Downstream Customer in Clinics
Figure Rheumatoid Arthritis Drugs Market Size (Million USD) and Growth Rate in Clinics (2012-2017)
Table Key Downstream Customer in Home Care
Figure Rheumatoid Arthritis Drugs Market Size (Million USD) and Growth Rate in Home Care (2012-2017)
Table Key Downstream Customer in Other
Figure Rheumatoid Arthritis Drugs Market Size (Million USD) and Growth Rate in Other (2012-2017)
Table Rheumatoid Arthritis Drugs Market Size (Million USD) by Players (2016 and 2017)
Figure Rheumatoid Arthritis Drugs Market Size Share by Players in 2016
Figure Rheumatoid Arthritis Drugs Market Size Share by Players in 2017
Table Merck Basic Information List
Table Rheumatoid Arthritis Drugs Business Revenue (Million USD) of Merck (2012-2017)
Figure Merck Rheumatoid Arthritis Drugs Business Revenue Market Share in 2016
Table Novartis Basic Information List
Table Rheumatoid Arthritis Drugs Business Revenue (Million USD) of Novartis (2012-2017)
Figure Novartis Rheumatoid Arthritis Drugs Business Revenue Market Share in 2016
Table Pfizer Basic Information List
Table Rheumatoid Arthritis Drugs Business Revenue (Million USD) of Pfizer (2012-2017)
Figure Pfizer Rheumatoid Arthritis Drugs Business Revenue Market Share in 2016
Table J&J Basic Information List
Table Rheumatoid Arthritis Drugs Business Revenue (Million USD) of J&J (2012-2017)
Figure J&J Rheumatoid Arthritis Drugs Business Revenue Market Share in 2016
Table BMS Basic Information List
Table Rheumatoid Arthritis Drugs Business Revenue (Million USD) of BMS (2012-2017)
Figure BMS Rheumatoid Arthritis Drugs Business Revenue Market Share in 2016
Table Abbvie Basic Information List
Table Rheumatoid Arthritis Drugs Business Revenue (Million USD) of Abbvie (2012-2017)
Figure Abbvie Rheumatoid Arthritis Drugs Business Revenue Market Share in 2016
Table Boehringer Ingelheim Basic Information List
Table Rheumatoid Arthritis Drugs Business Revenue (Million USD) of Boehringer Ingelheim (2012-2017)
Figure Boehringer Ingelheim Rheumatoid Arthritis Drugs Business Revenue Market Share in 2016
Table AstraZeneca Basic Information List
Table Rheumatoid Arthritis Drugs Business Revenue (Million USD) of AstraZeneca (2012-2017)
Figure AstraZeneca Rheumatoid Arthritis Drugs Business Revenue Market Share in 2016
Table MedImmune Basic Information List
Table Rheumatoid Arthritis Drugs Business Revenue (Million USD) of MedImmune (2012-2017)
Figure MedImmune Rheumatoid Arthritis Drugs Business Revenue Market Share in 2016
Table Takeda Basic Information List
Table Rheumatoid Arthritis Drugs Business Revenue (Million USD) of Takeda (2012-2017)
Figure Takeda Rheumatoid Arthritis Drugs Business Revenue Market Share in 2016
Table Biogen Idec Basic Information List
Table Rheumatoid Arthritis Drugs Business Revenue (Million USD) of Biogen Idec (2012-2017)
Figure Biogen Idec Rheumatoid Arthritis Drugs Business Revenue Market Share in 2016
Table Celgene Basic Information List
Table Rheumatoid Arthritis Drugs Business Revenue (Million USD) of Celgene (2012-2017)
Figure Celgene Rheumatoid Arthritis Drugs Business Revenue Market Share in 2016
Table Bristol-Myers Squibb Basic Information List
Table Rheumatoid Arthritis Drugs Business Revenue (Million USD) of Bristol-Myers Squibb (2012-2017)
Figure Bristol-Myers Squibb Rheumatoid Arthritis Drugs Business Revenue Market Share in 2016
Table Celltrion Basic Information List
Table Rheumatoid Arthritis Drugs Business Revenue (Million USD) of Celltrion (2012-2017)
Figure Celltrion Rheumatoid Arthritis Drugs Business Revenue Market Share in 2016
Table Global Rheumatoid Arthritis Drugs Market Size (Million USD) by Type (2012-2017)
Figure Global Rheumatoid Arthritis Drugs Market Size Share by Type in 2012
Figure Global Rheumatoid Arthritis Drugs Market Size Share by Type in 2013
Figure Global Rheumatoid Arthritis Drugs Market Size Share by Type in 2014
Figure Global Rheumatoid Arthritis Drugs Market Size Share by Type in 2015
Figure Global Rheumatoid Arthritis Drugs Market Size Share by Type in 2016
Figure Global Rheumatoid Arthritis Drugs Market Size Share by Type in 2017
Table Global Rheumatoid Arthritis Drugs Market Size (Million USD) by Application (2012-2017)
Figure Global Rheumatoid Arthritis Drugs Market Size (Million USD) by Application in 2012
Figure Global Rheumatoid Arthritis Drugs Market Size (Million USD) by Application in 2013
Figure Global Rheumatoid Arthritis Drugs Market Size (Million USD) by Application in 2014
Figure Global Rheumatoid Arthritis Drugs Market Size (Million USD) by Application in 2015
Figure Global Rheumatoid Arthritis Drugs Market Size (Million USD) by Application in 2016
Figure Global Rheumatoid Arthritis Drugs Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Rheumatoid Arthritis Drugs
Figure United States Rheumatoid Arthritis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Rheumatoid Arthritis Drugs Market Size (Million USD) by Players (2012-2017)
Figure United States Rheumatoid Arthritis Drugs Market Size Share by Players in 2016
Figure United States Rheumatoid Arthritis Drugs Market Size Share by Players in 2017
Figure EU Rheumatoid Arthritis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Rheumatoid Arthritis Drugs Market Size (Million USD) by Players (2012-2017)
Figure EU Rheumatoid Arthritis Drugs Market Size Share by Players in 2016
Figure EU Rheumatoid Arthritis Drugs Market Size Share by Players in 2017
Figure Japan Rheumatoid Arthritis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Rheumatoid Arthritis Drugs Market Size (Million USD) by Players (2012-2017)
Figure Japan Rheumatoid Arthritis Drugs Market Size Share by Players in 2016
Figure Japan Rheumatoid Arthritis Drugs Market Size Share by Players in 2017
Figure China Rheumatoid Arthritis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Rheumatoid Arthritis Drugs Market Size (Million USD) by Players (2012-2017)
Figure China Rheumatoid Arthritis Drugs Market Size Share by Players in 2016
Figure China Rheumatoid Arthritis Drugs Market Size Share by Players in 2017
Figure India Rheumatoid Arthritis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Rheumatoid Arthritis Drugs Market Size (Million USD) by Players (2012-2017)
Figure India Rheumatoid Arthritis Drugs Market Size Share by Players in 2016
Figure India Rheumatoid Arthritis Drugs Market Size Share by Players in 2017
Figure Southeast Asia Rheumatoid Arthritis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Rheumatoid Arthritis Drugs Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Rheumatoid Arthritis Drugs Market Size Share by Players in 2016
Figure Southeast Asia Rheumatoid Arthritis Drugs Market Size Share by Players in 2017
Figure Global Rheumatoid Arthritis Drugs Market Size (Million USD) by Regions (2017-2022)
Table Global Rheumatoid Arthritis Drugs Market Size (Million USD) by Regions (2017-2022)
Figure Global Rheumatoid Arthritis Drugs Market Size Share by Regions in 2017
Figure Global Rheumatoid Arthritis Drugs Market Size Share by Regions in 2022
Figure United States Rheumatoid Arthritis Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Rheumatoid Arthritis Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Rheumatoid Arthritis Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Rheumatoid Arthritis Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Rheumatoid Arthritis Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Rheumatoid Arthritis Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Rheumatoid Arthritis Drugs Market Size (Million USD) by Type (2017-2022)
Figure Global Rheumatoid Arthritis Drugs Market Size Share by Type in 2017
Figure Global Rheumatoid Arthritis Drugs Market Size Share by Type in 2022
Table Global Rheumatoid Arthritis Drugs Market Size (Million USD) by Application (2017-2022)
Figure Global Rheumatoid Arthritis Drugs Market Size (Million USD) by Application in 2017
Figure Global Rheumatoid Arthritis Drugs Market Size (Million USD) by Application in 2022